These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6248221)

  • 21. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience with the third generation cephalosporins, cefoperazone and cefotaxime: report.
    Reddy J
    N Z Med J; 1984 May; 97(755):293-6. PubMed ID: 6328390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pharmacokinetics of cefoperazone and cefamandole.
    Srinivasan S; Francke EL; Neu HC
    Antimicrob Agents Chemother; 1981 Feb; 19(2):298-301. PubMed ID: 6214988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limiting cefotaxime pediatric dosing to adult standards: a pharmacokinetic simulation study.
    Dulaney Lopez AM; Rodriguez JC; Lopez-Samblas AM; Estes KS
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):269-74. PubMed ID: 10395117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep.
    Guerrini VH; Filippich LJ; Cao GR; English PB; Bourne DW
    J Vet Pharmacol Ther; 1985 Jun; 8(2):120-7. PubMed ID: 4020943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical comparison of cefoperazone in complicated urinary tract infections using a double-blind method.
    Nishiura T
    Clin Ther; 1980; 3(Spec Issue):190-205. PubMed ID: 6446394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five cephalosporins: pharmacokinetics and their relation to antibacterial potency.
    Sohn C; Pitkin D; Grappel S; Zajac I; Actor P; Alexander F; Lentnek A; Wikler M; Stote R; Dubb J
    Clin Ther; 1984; 6(4):560-70. PubMed ID: 6467282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.
    Greenfield RA; Gerber AU; Craig WA
    Rev Infect Dis; 1983; 5 Suppl 1():S127-36. PubMed ID: 6221382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of cefotaxime serum and lung concentrations in 6 patients with thoracotomy (author's transl)].
    Pous J; Peltier M; Berthoumieu C; Monnier J
    Nouv Presse Med; 1981 Feb; 10(8):585-6. PubMed ID: 6259597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J; Francke EL; Saltzman M; Neu HC
    Ther Drug Monit; 1981; 3(1):71-4. PubMed ID: 6262952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous administration of cefepime.
    Walker P; Neuhauser MN; Tam VH; Willey JS; Palmer JL; Bruera E; Prince RA
    J Pain Symptom Manage; 2005 Aug; 30(2):170-4. PubMed ID: 16125032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.
    Neu HC
    Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetics and tolerance of Cefazedone compared with Cefazoline (author's transl)].
    Hitzenberger G; Jaschek I
    Wien Med Wochenschr; 1980 Feb; 130(3):135-42. PubMed ID: 7368759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans.
    Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():99-104. PubMed ID: 6296035
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of cefotaxime.
    Fu KP; Aswapokee P; Ho I; Matthijssen C; Neu HC
    Antimicrob Agents Chemother; 1979 Nov; 16(5):592-7. PubMed ID: 526000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefoperazone (Cefobid, Pfizer).
    Lyon JA
    Drug Intell Clin Pharm; 1983 Jan; 17(1):7-11. PubMed ID: 6218974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of cefoperazone in patients with neoplastic disease.
    Maksymiuk AW; LeBlanc BM; Brown NS; Ho DH; Bodey GP
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1037-41. PubMed ID: 6455966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.